[Skip to Navigation]
November 1988

Can Acquired Immunodeficiency Syndrome and Creutzfeldt-Jakob Disease Be Transmitted via Otologic Homografts?

Author Affiliations

From The Otology Group (Drs Glasscock and Jackson) and the Department of Otolaryngology, Vanderbilt University School of Medicine (Dr Knox), Nashville.

Arch Otolaryngol Head Neck Surg. 1988;114(11):1252-1255. doi:10.1001/archotol.1988.01860230046020

• Materials commonly employed in the preparation of otologic homografts such as ethanol and formaldehyde are effective in vitro in inactivating human immunodeficiency virus (HIV). However, to our knowledge, the complete permeation of homograft materials with preservative has not been demonstrated. Ethanol and formaldehyde have not been shown to be effective in inactivating the CreutzfeldtJakob agent. The literature on sterilization procedures for these agents is reviewed. Standard procedures for preparation of otologic homografts are examined. It is recommended that donor HIV serologic status be determined when otologic homografts must be used. Further research is required to determine the efficacy of otologic homograft sterilization techniques against HIV and CreutzfeldtJakob disease.

(Arch Otolaryngol Head Neck Surg 1988;114:1252-1255)